Perospirone

This classification denotes an anxiolytic with the molecular formula C23H30N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N303OK87DT, chemically known as 1h-isoindole-1,3(2h)-dione, 2-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)hexahydro-, cis- but generally known as perospirone, which bears US NIH Compound Identifier 115368. European Medicines Agency schedules Perospirone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09735MIG. The term PEROSPIRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). PEROSPIRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule perospirone under HS 29341000 and SITC 51579. As of Q4 2014, PEROSPIRONE remains the US FDA Preferred Term for this commodity. Perospirone bears US NLM identifiers UMLS ID C0084572 and NCI Concept Code C66358. SMILES: S1NC(N2CCN(CCCCN3C(=O)C4C(CCCC4)C3=O)CC2)C2C1CCCC2.